Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Pharmaceuticals	71.87M	66.64M	32.82M	71.06M	-
Pharmaceuticals Growth	7.85%	103.03%	-53.82%	-	-
Total	71.87M	66.64M	32.82M	71.06M	-
Total Growth	7.85%	103.03%	-53.82%	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
China	71.87M	66.64M	32.82M	71.06M	-
China Growth	7.85%	103.03%	-53.82%	-	-
Total	71.87M	66.64M	32.82M	71.06M	-
Total Growth	7.85%	103.03%	-53.82%	-	-

Source: S&P Global Market Intelligence.